193 related articles for article (PubMed ID: 9306332)
41. [Mesalazine-induced nephropathy].
Zaragoza Marcet A; Ivorra Cortés J
Rev Esp Enferm Dig; 2001 Aug; 93(8):548. PubMed ID: 11692787
[No Abstract] [Full Text] [Related]
42. Interstitial nephritis associated with ulcerative colitis in monozygotic twins.
Sato H; Umemura K; Yamamoto T; Sato H
BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28183711
[TBL] [Abstract][Full Text] [Related]
43. Mesalazine-associated interstitial nephritis.
World MJ; Stevens PE; Ashton MA; Rainford DJ
Nephrol Dial Transplant; 1996 Apr; 11(4):614-21. PubMed ID: 8671848
[TBL] [Abstract][Full Text] [Related]
44. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
Gisbert JP; González-Lama Y; Maté J
Inflamm Bowel Dis; 2007 May; 13(5):629-38. PubMed ID: 17243140
[TBL] [Abstract][Full Text] [Related]
45. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Ransford RA; Langman MJ
Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
[TBL] [Abstract][Full Text] [Related]
46. Allergic Interstitial Nephritis Masquerading as Pyelonephritis in a Pediatric Patient With Crohn Disease.
Lomboy JR; Jose F
J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):e18-e20. PubMed ID: 28644363
[No Abstract] [Full Text] [Related]
47. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease.
Goldstein F; DiMarino AJ
J Clin Gastroenterol; 2000 Jul; 31(1):60-2. PubMed ID: 10914779
[TBL] [Abstract][Full Text] [Related]
48. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
Heap GA; So K; Weedon M; Edney N; Bewshea C; Singh A; Annese V; Beckly J; Buurman D; Chaudhary R; Cole AT; Cooper SC; Creed T; Cummings F; de Boer NK; D'Inca R; D'Souza R; Daneshmend TK; Delaney M; Dhar A; Direkze N; Dunckley P; Gaya DR; Gearry R; Gore S; Halfvarson J; Hart A; Hawkey CJ; Hoentjen F; Iqbal T; Irving P; Lal S; Lawrance I; Lees CW; Lockett M; Mann S; Mansfield J; Mowat C; Mulgrew CJ; Muller F; Murray C; Oram R; Orchard T; Parkes M; Phillips R; Pollok R; Radford-Smith G; Sebastian S; Sen S; Shirazi T; Silverberg M; Solomon L; Sturniolo GC; Thomas M; Tremelling M; Tsianos EV; Watts D; Weaver S; Weersma RK; Wesley E; Holden A; Ahmad T
J Crohns Colitis; 2016 Feb; 10(2):149-58. PubMed ID: 26619893
[TBL] [Abstract][Full Text] [Related]
49. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
[No Abstract] [Full Text] [Related]
50. Acute interstitial nephritis due to mesalazine.
Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
[TBL] [Abstract][Full Text] [Related]
51. [Recent therapeutic modalities in chronic inflammatory bowel diseases: 4- or 5-aminosalicylic acid?].
Allgayer H; Klotz U; Böhne P; Schmidt M; Kruis W
Z Gastroenterol; 1994 Nov; 32(11):647-50. PubMed ID: 7886975
[TBL] [Abstract][Full Text] [Related]
52. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
53. MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis.
Halbritter J; Wittenburg H; Schiefke I; Amann K; Lindner T; Rasche FM
Inflamm Bowel Dis; 2012 Mar; 18(3):E599-600. PubMed ID: 22147390
[No Abstract] [Full Text] [Related]
54. 5-Aminosalicylates and effects on renal function in patients with Crohn's disease.
de Jong DJ; Tielen J; Habraken CM; Wetzels JF; Naber AH
Inflamm Bowel Dis; 2005 Nov; 11(11):972-6. PubMed ID: 16239842
[TBL] [Abstract][Full Text] [Related]
55. Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
Iofel E; Chawla A; Daum F; Markowitz J
J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):73-6. PubMed ID: 11753169
[No Abstract] [Full Text] [Related]
56. Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid.
Hayashi D; Nishida T; Osugi N; Kusunoki Y; Okabe S; Fujii Y; Nakamatsu D; Matsumoto K; Yamamoto M; Fukui K
Intern Med; 2024 Apr; 63(8):1081-1085. PubMed ID: 37661446
[TBL] [Abstract][Full Text] [Related]
57. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].
Frol'kis AV
Ter Arkh; 1996; 68(2):75-7. PubMed ID: 8771669
[No Abstract] [Full Text] [Related]
58. Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
Present DH
Gastroenterology; 2000 Jul; 119(1):276. PubMed ID: 10928833
[No Abstract] [Full Text] [Related]
59. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
60. Hypersensitivity to 5-ASA suppositories.
Weidenhiller M; Raithel M; Hahn EG
Dig Dis Sci; 1999 Dec; 44(12):2552-3. PubMed ID: 10630512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
